- Home
- GCI vs ORIC Comparison
GCI vs ORIC Comparison
Compare GCI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCI
- ORIC
- Stock Information
- Founded
- GCI 1997
- ORIC 2014
- Country
- GCI United States
- ORIC United States
- Employees
- GCI N/A
- ORIC N/A
- Industry
- GCI Newspapers/Magazines
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- GCI Consumer Discretionary
- ORIC Health Care
- Exchange
- GCI Nasdaq
- ORIC Nasdaq
- Market Cap
- GCI 549.7M
- ORIC 545.5M
- IPO Year
- GCI N/A
- ORIC 2020
- Fundamental
- Price
- GCI $3.00
- ORIC $7.70
- Analyst Decision
- GCI Buy
- ORIC Strong Buy
- Analyst Count
- GCI 3
- ORIC 9
- Target Price
- GCI $5.70
- ORIC $18.43
- AVG Volume (30 Days)
- GCI 1.6M
- ORIC 981.7K
- Earning Date
- GCI 05-01-2025
- ORIC 05-05-2025
- Dividend Yield
- GCI N/A
- ORIC N/A
- EPS Growth
- GCI N/A
- ORIC N/A
- EPS
- GCI N/A
- ORIC N/A
- Revenue
- GCI $2,509,315,000.00
- ORIC N/A
- Revenue This Year
- GCI N/A
- ORIC N/A
- Revenue Next Year
- GCI N/A
- ORIC N/A
- P/E Ratio
- GCI N/A
- ORIC N/A
- Revenue Growth
- GCI N/A
- ORIC N/A
- 52 Week Low
- GCI $1.97
- ORIC $6.33
- 52 Week High
- GCI $5.93
- ORIC $15.40
- Technical
- Relative Strength Index (RSI)
- GCI 18.15
- ORIC 41.92
- Support Level
- GCI $3.10
- ORIC $7.22
- Resistance Level
- GCI $4.09
- ORIC $8.11
- Average True Range (ATR)
- GCI 0.21
- ORIC 0.58
- MACD
- GCI -0.08
- ORIC 0.04
- Stochastic Oscillator
- GCI 1.81
- ORIC 20.78
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.